TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+25.01%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$251M
AUM Growth
+$6.37M
(+2.6%)
Cap. Flow
-$27.1M
Cap. Flow
% of AUM
-10.76%
Top 10 Holdings %
Top 10 Hldgs %
83.47%
Holding
27
New
5
Increased
8
Reduced
5
Closed
5
Top Buys
| 1 |
Pacira BioSciences
PCRX
|
$12.2M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.3M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$10M |
| 4 |
Medtronic
MDT
|
$6.83M |
| 5 |
Alkermes
ALKS
|
$5.11M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$24.8M |
| 2 |
NovoCure
NVCR
|
$22.4M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$17.9M |
| 4 |
Service Corp International
SCI
|
$6.22M |
| 5 |
McKesson
MCK
|
$5.52M |
Sector Composition
| 1 | Healthcare | 77% |
| 2 | Industrials | 11.04% |
| 3 | Consumer Discretionary | 1.92% |